Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Feb;17(2):247–250. doi: 10.1128/aac.17.2.247

Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.

M F Rein, W C Elliott, J M Swenson, C Thornsberry
PMCID: PMC283765  PMID: 6770754

Abstract

Sulfamethoxazole and trimethoprim are synergistic against many bacteria in sulfamethoxazole/trimethoprim concentrations of 20:1, but single-dose therapy of gonorrhea with the combination is disappointing. We used agar dilution techniques to determine minimal inhibitory concentrations of sulfamethoxazole and trimethoprim for 168 gonococci isolated from men with acute urethritis in Atlanta, Ga. The geometric mean minimal inhibitory concentrations were 5.6 microgram of sulfamethoxazole per ml and 24.3 microgram of trimethoprim per ml, a ratio of 1:4. The concentration of sulfamethoxazole inhibiting 50% of gonococcal strains dropped only from 4.7 microgram/ml to 2.9 microgram/ml with the addition of a 1/20 dilution of trimethoprim. We studied synergism with various ratios of sulfamethoxazole to trimethoprim against 20 random strains. A ratio of 1:1 was always synergistic and was the most synergistic ratio for 15 strains, whereas the 19:1 ratio was never the most syngergistic. The 19:1 ratio failed to show synergism against seven strains, but showed antagonism at this ratio with five of these seven. The sulfamethoxazole/trimethoprim ratio of 19:1 usually achieved in serum after oral administration is minimally syngergistic and is sometimes antagonistic for gonococci.

Full text

PDF
247

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Duncan W. C., Knox J. M., Jackson T. H. Trimethoprim-sulfamethoxazole in the treatment of gonorrhea: comparison with standard treatment schedules. South Med J. 1975 Sep;68(9):1147–1152. doi: 10.1097/00007611-197509000-00020. [DOI] [PubMed] [Google Scholar]
  2. Elliott W. C., Reynolds G., Thornsberry C., Kellogg D. S., Jaffe H. W., Brown S. T., Armstrong J., Rein M. F. Treatment of gonorrhea with trimethoprim-sulfamethoxazole. J Infect Dis. 1977 Jun;135(6):939–943. doi: 10.1093/infdis/135.6.939. [DOI] [PubMed] [Google Scholar]
  3. Fass R. J., Prior R. B., Perkins R. L. Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg). Antimicrob Agents Chemother. 1977 Jul;12(1):102–106. doi: 10.1128/aac.12.1.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jaffe H. W., Schroeter A. L., Reynolds G. H., Zaidi A. A., Martin J. E., Jr, Thayer J. D. Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob Agents Chemother. 1979 Apr;15(4):587–591. doi: 10.1128/aac.15.4.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kremers P., Duvivier J., Heusghem C. Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. J Clin Pharmacol. 1974 Feb-Mar;14(2):112–117. doi: 10.1002/j.1552-4604.1974.tb02300.x. [DOI] [PubMed] [Google Scholar]
  6. Meheus A. Z., Ngamije E., Freyens P. Treatment of gonorrhoea with trimethoprim-sulphamethoxazole and probenecid plus procaine penicillin in Rwanda. Br J Vener Dis. 1974 Dec;50(6):447–449. doi: 10.1136/sti.50.6.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Phillips I., Ridley M., Rimmer D., Lynn R. In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae. Lancet. 1970 Feb 7;1(7641):263–265. doi: 10.1016/s0140-6736(70)90635-5. [DOI] [PubMed] [Google Scholar]
  9. Prior R. B., Fass R. J., Perkins R. L. A single large dose of trimethoprim-sulfamethoxazole fails to cure gonococcal urethritis in men. Sex Transm Dis. 1978 Apr-Jun;5(2):62–64. doi: 10.1097/00007435-197804000-00006. [DOI] [PubMed] [Google Scholar]
  10. Rahal J. J., Jr Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine (Baltimore) 1978 Mar;57(2):179–195. [PubMed] [Google Scholar]
  11. Rahim G. Single-dose treatment of gonorrhoea with cotrimoxazole. A report on 1,223 cases. Br J Vener Dis. 1975 Jun;51(3):179–182. doi: 10.1136/sti.51.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rieder J., Schwartz D. E., Fernex M., Bergan T., Brodwall E. K., Blumberg A., Cottier P., Scheitlin W. Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. Antibiot Chemother (1971) 1974;18:148–198. doi: 10.1159/000395184. [DOI] [PubMed] [Google Scholar]
  13. Stolz E., Michel M. F., Zwart H. G. Potentiation of sulphamethoxazole by trimethoprim in Neisseria gonorrhoeae strains. Chemotherapy. 1977;23(2):65–72. doi: 10.1159/000221973. [DOI] [PubMed] [Google Scholar]
  14. Weinstein R. J., Young L. S., Hewitt W. L. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia. J Lab Clin Med. 1975 Nov;86(5):853–862. [PubMed] [Google Scholar]
  15. Yoshikawa T. T., Guze L. B. Concentrations of trimethoprim-sulfamethoxazole in blood after a single, large oral dose. Antimicrob Agents Chemother. 1976 Sep;10(3):462–463. doi: 10.1128/aac.10.3.462. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES